Sage Therapeutics (SAGE.O) has priced the oral postpartum depression (PPD) pill it developed with partner Biogen (BIIB.O) at $15,900 for a full 14-day course of treatment, the company said on Tuesday, months after the drug was approved by the U.S. health regulator.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.